On Friday, the FDA expanded its approved use for kids 6 years and older who have Type 1 diabetes or those who require insulin ...
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the ...
Following FDA Commissioner Marty Makary’s recent resignation, the incoming commissioner has a powerful opportunity to follow through on the FDA’s promises to enact commonsense approaches to getting ...
As the FDA''s deputy commissioner for food, Diamantas, a former food and drug attorney, led the agency's Human Foods Program ...
The U.S. could soon see its biggest shift in sunscreen regulation in over 25 years as the FDA considers approving a new UV ...
Money Talks News on MSN
A simple blood test claims to detect 50 cancers but isn't FDA-approved yet
A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...
E-cigarettes may carry cancer risks of their own, researchers warn. A doctor explains what people who vape and parents should ...
The American Cancer Society is adding some new testing options to its screening guideline for colorectal cancers – and for ...
FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity ...
Morning Overview on MSN
A new FDA-approved pill just won fast-tracked approval for an aggressive blood cancer — a drug that flips off the survival switch keeping lymphoma cells alive
For the roughly 4,000 to 5,000 Americans diagnosed with mantle cell lymphoma each year, running out of treatment options can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results